Regioselective synthesis and molecular modeling study of vasorelaxant active 7,9-dioxa-1,2-diaza-spiro[4.5]dec-2-ene-6,10-diones

被引:33
作者
Girgis, Adel S. [1 ]
Ismail, Nasser S. M. [2 ]
Farag, Hanaa [1 ]
El-Eraky, Wafaa I. [3 ]
Saleh, Dalia O. [3 ]
Tala, Srinivasa R. [4 ]
Katritzky, Alan R. [4 ]
机构
[1] Natl Res Ctr, Dept Pesticide Chem, Cairo 12622, Egypt
[2] Ain Shams Univ, Dept Pharmaceut Chem, Fac Pharm, Cairo 11566, Egypt
[3] Natl Res Ctr, Dept Pharmacol, Cairo 12622, Egypt
[4] Univ Florida, Dept Chem, Ctr Heterocycl Cpds, Gainesville, FL 32611 USA
关键词
5-Arylidene-2,2-dimethyl[1,3]dioxane-4,6-diones; Hydrazonoyl halides; 7,9-Dioxa-1,2-diaza-spiro[4.5]dec-2-ene-6,10-diones; Dipolar cycloaddition; Vasodilation; Molecular modeling; URINARY-TRACT SYMPTOMS; DERIVATIVES; DESIGN; ANTAGONISTS; ACID;
D O I
10.1016/j.ejmech.2010.06.018
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Nitrilimines (PhC-:N+:NR') generated in situ from hydrazonoyl chlorides 2a,b reacted regioselectively with 5-arylidene-2,2-dimethyl[1,3]dioxane-4,6-diones 1a-f to afford 1.3,4-triaryl-8,8-dimethyl-7,9-dioxa-1,2-diaza-spiro[4.5]dec-2-ene-6,10-diones 3a-1. In vitro vasodilation activity screening of the synthesized compounds using isolated thoracic aortic rings of male Wister rats pre-contracted with norepinephrine hydrochloride revealed considerable vasodilation activity: compounds 3f and 3j had IC50 (concentration necessary for 50% reduction of maximal norepinephrine hydrochloride induced contracture) of 0.325, 0.321 mM, respectively. Molecular modeling, including fitting to a 3D-pharma-cophore model using Discovery studio 2.1 programs and their docking into optimized alpha(1)-AR homology models as alpha(1)-AR antagonist showed high-docking score and fit values. The experimental in vitro vasodilation activity of compounds 3a-1 was consistent with the molecular modeling. (C) 2010 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:4229 / 4238
页数:10
相关论文
共 32 条
[1]   Synthesis and biological activity of new 1,4-benzodioxanarylpiperazine derivatives.: Further validation of a pharmacophore model for α1-adrenoceptor antagonists [J].
Barbaro, R ;
Betti, L ;
Botta, M ;
Corelli, F ;
Giannaccini, G ;
Maccari, L ;
Manetti, F ;
Strappaghetti, G ;
Corsano, S .
BIOORGANIC & MEDICINAL CHEMISTRY, 2002, 10 (02) :361-369
[2]   An expeditious approach to Knoevenagel condensation of Meldrum's acid on neutral alumina using microwave irradiation [J].
Chakrabarty, Manas ;
Mukherjee, Ratna ;
Chakrabarty, Manju ;
Arima, Shiho ;
Harigaya, Yoshihiro .
LETTERS IN ORGANIC CHEMISTRY, 2006, 3 (11) :868-871
[3]   Pharmacological therapy of benign prostatic hyperplasia/lower urinary tract symptoms: an overview for the practising clinician [J].
Chapple, CR .
BJU INTERNATIONAL, 2004, 94 (05) :738-744
[4]   (Phenylpiperazinyl)cyclohexylureas:: Discovery of α1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS) [J].
Chiu, George ;
Li, Shengjian ;
Connolly, Peter J. ;
Pulito, Virginia ;
Llu, Jingchun ;
Middleton, Steven A. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (02) :640-644
[5]   REACTIVITY OF ARYLIDENE BENZOTHIAZINONE DIOXIDES IN [3+2]-CYCLOADDITIONS - COMPETITION BETWEEN DIPOLAROPHILIC SITES - FORMATION OF CYCLOADDUCTS [J].
FATHI, T ;
CIAMALA, K ;
AN, ND ;
VEBREL, J .
CANADIAN JOURNAL OF CHEMISTRY-REVUE CANADIENNE DE CHIMIE, 1994, 72 (06) :1424-1428
[6]   Synthesis of new 3-pyridinecarboxylates of potential vasodilation properties [J].
Girgis, Adel S. ;
Mishriky, Nawal ;
Farag, Ahmad M. ;
El-Eraky, Wafaa I. ;
Farag, Hanaa .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2008, 43 (09) :1818-1827
[7]   Synthesis of novel vasodilatory active nicotinate esters with amino acid function [J].
Girgis, Adel S. ;
Kalmouch, Atef ;
Ellithey, Whey .
BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (24) :8488-8494
[8]   Regioselective synthetic approaches towards 1,2,8,9-tetraazadispiro[4.1.4.2]trideca-2,9-dien-6-ones of potential antimicrobial properties [J].
Girgis, Adel S. ;
Barsoum, Flora F. ;
Samir, Ahmed .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2009, 44 (06) :2447-2451
[9]  
Girgis AS, 2006, J CHEM RES-S, P81
[10]  
Girgis AS, 2000, J CHEM RES-S, P508